"The parties have signed a binding term sheet and are in the process of preparing the final agreement. Good cause exists to ...
Biotech giant Regeneron Pharmaceuticals (NASDAQ: REGN) started 2024 on a strong note and performed well through the first ...
The Japanese pharma company files complaint against Lupin Pharmaceuticals | Suit alleges patent infringement over the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback